These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6125982

  • 1. Effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Meltzer HY, Busch DA, Tricou BJ, Robertson A.
    Psychiatry Res; 1982 Jun; 6(3):313-26. PubMed ID: 6125982
    [Abstract] [Full Text] [Related]

  • 2. Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report.
    Tamminga CA, Tighe PJ, Chase TN, DeFraites EG, Schaffer MH.
    Arch Gen Psychiatry; 1981 Feb; 38(2):167-8. PubMed ID: 7212942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M, Laforge E, Muyard J, Blayac J, Lemoine J.
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A treatment trial with an analog of thyrotropin-releasing hormone (DN-1417) and des-tyrosine-gamma-endorphin in schizophrenia.
    Mizuki Y, Ushijima I, Yamada M, Tanaka M, Inanaga K.
    Int Clin Psychopharmacol; 1986 Oct; 1(4):303-13. PubMed ID: 2881964
    [Abstract] [Full Text] [Related]

  • 7. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM, Westenberg HG, Gerritsen TW, van Praag HM, Thijssen JH, Schwarz F, van Ree JM, de Wied D.
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM, Verhoeven WM, Van Praag HM, De Wied D.
    Mod Probl Pharmacopsychiatry; 1981 Dec; 17():266-78. PubMed ID: 6173744
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
    Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS.
    Psychiatry Res; 1984 Apr; 11(4):329-46. PubMed ID: 6204351
    [Abstract] [Full Text] [Related]

  • 12. (Des-Tyr)gamma-endorphin for schizophrenia. A critical review.
    Manchanda R, Hirsch SR.
    Int Pharmacopsychiatry; 1982 Apr; 17(3):147-52. PubMed ID: 6128328
    [Abstract] [Full Text] [Related]

  • 13. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM, Zaudig M, v Zerssen D, Kissling W, Dirlich G, Herz A.
    Mod Probl Pharmacopsychiatry; 1981 Apr; 17():279-86. PubMed ID: 7329421
    [No Abstract] [Full Text] [Related]

  • 14. Criteria for evaluating improvement in schizophrenia in psychopharmacological research (with special reference to gamma endorphin fragments).
    Manchanda R, Hirsch SR, Barnes TR.
    Br J Psychiatry; 1988 Sep; 153():354-8. PubMed ID: 3250672
    [Abstract] [Full Text] [Related]

  • 15. Clinical, electrophysiological, and biochemical effects of des-tyrosine-gamma-endorphin in psychiatric patients.
    Metz J, Busch DA, Meltzer HY.
    Ann N Y Acad Sci; 1982 Sep; 398():496-508. PubMed ID: 6961867
    [No Abstract] [Full Text] [Related]

  • 16. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM, Verhoeven WM, van Ree JM, de Wied D.
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [Abstract] [Full Text] [Related]

  • 17. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients.
    Verhoeven WM, van Ree JM, Heezius-van Bentum A, de Wied D, van Praag HM.
    Arch Gen Psychiatry; 1982 Jun; 39(6):648-54. PubMed ID: 7092498
    [Abstract] [Full Text] [Related]

  • 18. High-dose destyrosine-gamma-endorphin in tardive dyskinesia.
    Korsgaard S, Casey DE, Gerlach J.
    Psychopharmacology (Berl); 1982 Jun; 78(3):285-6. PubMed ID: 6130557
    [Abstract] [Full Text] [Related]

  • 19. Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE).
    Verhoeven WM, van Praag HM, van Ree JM, de Wied D.
    Arch Gen Psychiatry; 1979 Mar; 36(3):294-8. PubMed ID: 369471
    [Abstract] [Full Text] [Related]

  • 20. [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].
    Verhoeven VM.
    Encephale; 1987 Mar; 13(6):349-56. PubMed ID: 2453339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.